-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $11

Benzinga·02/26/2026 15:54:39
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $13 to $11.